Genomic Test Detects Drug-resistant Mutation in TB Bacteria

by Ramya Rachamanti on  August 9, 2019 at 6:00 PM Genetics & Stem Cells News
RSS Email Print This Page Comment bookmark
Font : A-A+

Genomic sequencing-based test detects drug-resistant mutation in Tuberculosis (TB) bacteria. It was developed by genetic diagnostic and drug discovery research firm MedGeneome Labs.
Genomic Test Detects Drug-resistant Mutation in TB Bacteria
Genomic Test Detects Drug-resistant Mutation in TB Bacteria

"The breakthrough DNA test will enable a doctor to correctly prescribe the most effective drug to a TB patient without a time-consuming trial and error process," said the city-based clinical data-driven Labs.

Show Full Article


Announcing its foray into infectious disease testing in TB, central nervous system (CNS), systemic and eye infections, the company said India had the largest number of multi-drug resistant (MDR) TB cases.

"India has the largest number of MDR-TB cases. Our spit sequence can be a boon for TB patients, clinicians and healthcare agencies to achieve the sustainable development goal of eliminating TB by 2025," Labs Chief Operating Officer V.L. Ramprasad told reporters here.

"The test is based on the whole genome sequencing of mycobacterium tuberculosis (MTB), the TB causing bacteria, to assess the mutations in bacteria's genome and allows a clinician to determine which drug will work for a patient," he said.

Mumbai-based P.D. Hinduja Hospital and Medical Research Centre head Camilla Rodrigues said the test was validated with 100 samples recording 100 per cent sensitivity and 98.04 per cent specificity compared with line probe assay technology.

"Of the 100 samples, 50 were tested in our hospital. The findings in the manuscript are under review for publication," Rodrigues said on the occasion.

Noting that the process of analyzing the drug resistance was long, which is delaying early treatment for MDR-TB patient, Rodrigues said the current expertise allowed testing resistance only on 4 drugs, which makes the patient wait until testing on all possible drugs concluded.

"Direct whole genome sequencing reveals information on drug resistance mutations for all anti-TB drugs in 10 days. Our testing will help to optimise the management of an MDR-TB patient", she added.

IANS

Source: IANS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Recommended Reading

More News on:

Tuberculosis AIDS/HIV Shigellosis Undescended Testicles Varicocele MRSA - The Super Bug Silicosis Screening Tests for Tuberculosis McArdle Disease Food Safety for Health 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive